RecruitingPreeclampsia (PE)

Non-Invasive Preeclampsia Screening and Biobank

Eligible age

18+ yrs

Accepts

Women

Locations

12 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.

Sponsor: Sequenom, Inc.

✓ Subject is female and 18 years of age and older;
✓ Subject provides a signed and dated informed consent;
✓ Subject is pregnant with a singleton pregnancy at ≥11.0 - ≤14.0 weeks' gestation;
✓ Subject agrees to provide the Sponsor access to any prenatal and postnatal screening or diagnostic test results and supporting data;
✓ Subject agrees to have UtAPI calculated during their SOC first trimester ultrasound and MAP collected at the first trimester SOC visit;
✓ Subject agrees to provide up to 25mL of whole blood at each trimester visit;
✓ Subject agrees to provide relevant medical and pregnancy/postnatal information including outcome.

✕ Subject is unlikely to return for second and third trimester testing;
✕ Subject is unlikely to have pregnancy outcome data available;
✕ Previous sample donation under this protocol with the same pregnancy;
✕ Subject is participating in a blinded aspirin study or taking unknown doses of aspirin.